SARS-CoV-2 Nucleocapsid antibody
Quick Overview for SARS-CoV-2 Nucleocapsid antibody (ABIN6952935)
Target
See all SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N) AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Purification
- Purified by Protein G.
-
Isotype
- IgG2b
-
-
-
-
Application Notes
- WB(1:500-2000), ELISA(1:500-1000)
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- ≥ 1 mg/mL
-
Buffer
- 0.01M PBS( pH 7.4) with 0.1 % Proclin300
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
-
-
- SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N)
-
Alternative Name
- SARS-CoV-2 Nucleocapsid Protein
-
Target Type
- Viral Protein
-
Background
- Coronaviruses are enveloped viruses with a positive-sense RNA genome and with a nucleocapsid of helical symmetry. Coronavirus nucleoproteins localize to the cytoplasm and the nucleolus, a subnuclear structure, in both virus-infected primary cells and in cells transfected with plasmids that express N protein. Coronavirus N protein is required for coronavirus RNA synthesis, and has RNA chaperone activity that may be involved in template switch. Nucleocapsid protein is a most abundant protein of coronavirus. During virion assembly, N protein binds to viral RNA and leads to formation of the helical nucleocapsid. Nucleocapsid protein is a highly immunogenic phosphoprotein also implicated in viral genome replication and in modulating cell signaling pathways. Because of the conservation of N protein sequence and its strong immunogenicity, the N protein of coronavirus is chosen as a diagnostic tool.
Target
-